Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review.
Emma J RagelLynda K HarrisRichard A CampbellPublished in: BMJ open respiratory research (2023)
As ongoing CARDS clinical trials progress, their findings are likely to have important implications that alter the management of ARDS in patients that develop the condition from illnesses other than COVID-19 in the future.
Keyphrases
- acute respiratory distress syndrome
- coronavirus disease
- extracorporeal membrane oxygenation
- sars cov
- mechanical ventilation
- clinical trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- physical activity
- prognostic factors
- patient reported outcomes
- climate change
- respiratory syndrome coronavirus
- study protocol
- human health
- phase ii